2,3,4,6-tetrachlorophenol has been researched along with Staphylococcal Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Brun, YV; Coombes, BK; Culp, EJ; Fiebig-Comyn, AA; Hsu, YP; Koteva, K; Sychantha, D; Van Nieuwenhze, MS; Waglechner, N; Wang, W; Wright, GD | 1 |
| Kim, HJ; Kim, WG; Kwon, YJ | 1 |
| ANDERSEN, AA | 1 |
3 other study(ies) available for 2,3,4,6-tetrachlorophenol and Staphylococcal Infections
| Article | Year |
|---|---|
Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling.
Topics: Actinobacteria; Animals; Anti-Bacterial Agents; Biosynthetic Pathways; Cell Wall; Chlorophenols; Disease Models, Animal; Drug Discovery; Drug Resistance, Microbial; Female; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Multigene Family; N-Acetylmuramoyl-L-alanine Amidase; Peptides, Cyclic; Peptidoglycan; Phylogeny; Skin; Staphylococcal Infections | 2020 |
Complestatin exerts antibacterial activity by the inhibition of fatty acid synthesis.
Topics: Anti-Bacterial Agents; Chlorophenols; Drug Resistance; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enzyme Inhibitors; Fatty Acids; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oligopeptides; Peptides, Cyclic; Staphylococcal Infections; Staphylococcus aureus; Streptomyces | 2015 |
Evaluation of a new bactericidal spray effective against Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Bacillus subtilis; Biphenyl Compounds; Chlorophenols; Phenols; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections | 1963 |